E

Tier

Fisetin

Fisetin

Fisetin

Plant flavonoid studied as a senolytic (not a peptide).

Longevity & Cellular Health

Plant flavonoid, not a peptide

WADA Status:

Not prohibited

Human Trial Scoreboard

Completed human RCTs

0
0
0

Early phase, pending

Largest Human Study

0
0
0

Size not verified

Longest exposure

0
0
0

Duration not verified

Most Recent Trial

0
0
0

Results pending

Description

Fisetin is not a peptide. It is a flavonoid, a plant compound found in strawberries, apples and onions, and it is one of the more credible senolytic candidates. Senolytics work by selectively killing senescent cells, damaged cells that stop dividing but do not die, instead lingering in tissue and releasing inflammatory signals that appear to drive much of what we experience as ageing. In animal studies fisetin cleared these cells and extended lifespan. What distinguishes it from most things in this database is that the human trials are actually happening, run by the Mayo Clinic and others, several of them registered and ongoing. Results are largely still pending, which is a more honest position than almost anything else here.

What Are The Claims

Claims made for this compound: Senolytic; Anti-inflammatory antioxidant

Evidence

The gap between the trial protocols and the commercial product is unusually concrete here. Human senolytic trials, including AFFIRM at the Mayo Clinic under registry number NCT03430037, plus COVID-FIS and SToMP-AD, use intermittent pulsed dosing: a short course of consecutive days, repeated after an interval of weeks. Commercial fisetin products are sold and labeled for daily use. Those are different interventions. More fundamentally, no published human trial has yet demonstrated a senolytic effect in people. The trials are running and blinded efficacy data remain unpublished. Senolysis in humans is currently a hypothesis under investigation, not a finding, and fisetin is sold as though that question were settled.

Evidence Strength

Animal/preclinical + early human (trials ongoing)

Caveats

Available as a dietary supplement OTC; not FDA-approved as a drug; senolytic evidence is preliminary and largely limited to preclinical models; human trials are early-phase and small.

Safety
Alternative Measures
Legal Status

US

Dietary supplement

UK

Supplement

EU

Supplement

AU

Supplement

WADA

Not prohibited

A flavonoid present in foods including strawberries and apples, sold as a dietary supplement. Not an approved drug and not approved for any senolytic indication.

Citations

AFFIRM trial, NCT03430037, Mayo Clinic, Phase IIb, intermittent pulsed dosing protocol. | COVID-FIS and SToMP-AD trials, pulsed dosing. | No published human trial has demonstrated senolytic effect to date.

The content on this site is provided for general informational purposes only and is not intended as medical advice, diagnosis, or treatment. Aambrosia sells subscription access to editorial and research content only, no supplement, compound, or other physical product discussed on this site is sold, shipped, or dispensed by Aambrosia. Always consult a qualified healthcare provider before making changes to your diet, supplement routine, or health practices. Aambrosia does not guarantee specific results, and individual outcomes may vary

Culver City California
Support: bio.aambrosia@gmail.com